1 completed, 1 recruiting, 1 withdrawn. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Recruiting 1, Withdrawn 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Desmoid: new trials by email Literature Review of Desmoid trials Research Report on Desmoid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FOG-001 in Locally Advanced or Metastatic Solid Tumors FOG-001, mFOLFOX-6, Nivolumab - Cancer, Colorectal Cancer | Phase 1 / Phase 2 | Recruiting | Parabilis Medicines, Inc. | 619 | 2023-05-23 | 2026-10-07 |
| HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors Doxorubicin HCl liposomal injection, Philips Sonalleve MR-HIFU Hyperthermia - Rhabdomyosarcoma, Neuroblastoma | Phase 1 | Withdrawn | Theodore Laetsch | 2016-12-01 | 2019-03-19 | |
| Endoxifen in Adults With Hormone Receptor Positive Solid Tumors Z-Endoxifen - Hormone Receptor-Positive Breast, Gynecologic | Phase 1 | Completed | National Cancer Institute (NCI) | 40 | 2011-03-01 | 2025-12-23 |
Desmoid Tumors (3) · Endometrial Neoplasms (2) · Adenomatous Polyposis Coli (1) · Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Colorectal Neoplasms (1) · Craniopharyngioma (1) · Fallopian Tube Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Neuroblastoma (1) · Osteosarcoma (1) · Ovarian Neoplasms (1) · Prostatic Neoplasms (1) · Rhabdomyosarcoma (1)
Fibroma (3) · Neoplasms by Histologic Type (3) · Neoplasms, Connective Tissue (3) · Neoplasms, Connective and Soft Tissue (3) · Neoplasms, Fibrous Tissue (3) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2) · Neoplasms (2) · Neoplasms by Site (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Nerve Tissue (2)
4-hydroxy-N-desmethyltamoxifen (1) · Bevacizumab (1) · Fluorouracil (1) · Leucovorin (1) · Nivolumab (1) · Oxaliplatin (1) · liposomal doxorubicin (1) · trifluridine tipiracil drug combination (1)
National Cancer Institute (NCI) (1) · Parabilis Medicines, Inc. (1) · Theodore Laetsch (1)
United States (3) · Australia (1)
Alice P Chen, M.D. (1) · Benjamin Oshrine (1)